title: [The use of drug vitaprost forte in patients with benign prostate hyperplasia].
abstract: The efficacy and safety of vitaprost forte rectal suppositories 100 mg in 30 patients with benign prostate hyperplasia (BPH) were evaluated. It is proven, that the use of this drug positively affects both the subjective and the objective symptoms of BPH. Vitaprost forte significantly reduces the clinical signs of the disease and improves quality of life, that is, reduces the severity of bladder outlet obstruction (according to the data of uroflowmetry, it increases maximum urinary flow rate), decreases the amount of residual urine. In addition, moderate reduction in mean prostate volume was revealed in BPH patients receiving vitaprost forte.
authors: B A
authors: BA
authors: Neĭmark
authors: A I
authors: AI
authors: Neĭmark
authors: N A
authors: NA
authors: Nozdrachev
mesh_terms: D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D011788:Quality of Life
chemical_list: D010455:Peptides; C524164:Vitaprost